Page last updated: 2024-10-29

ketamine and Urethral Neoplasms

ketamine has been researched along with Urethral Neoplasms in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Urethral Neoplasms: Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benrath, J1
Scharbert, G1
Gustorff, B1
Adams, HA1
Kress, HG1

Other Studies

1 other study available for ketamine and Urethral Neoplasms

ArticleYear
Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain.
    British journal of anaesthesia, 2005, Volume: 95, Issue:2

    Topics: Analgesics; Clonidine; Drug Tolerance; Humans; Injections, Spinal; Ketamine; Lumbar Vertebrae; Male;

2005